CEO says Mylan isn't getting rich off EpiPen

September 20, 2016 10:33 PM

19 0

The CEO of Mylan, which has come under fire for drastically raising the price of its EpiPen, says it's "not true" the company reaps huge profits off its lifesaving allergy treatment.

That's according to testimony Heather Bresch is set to present at a hearing on Wednesday before the House Oversight Committee. Its top members said last week they are sympathetic to the "justified outrage" of families and schools struggling to afford the device.

Read more

To category page